Institutional Biosafety Committee (IBC)

The Institutional Biosafety Committee (IBC) reviews, approves and oversees research involving the use of recombinant or synthetic DNA/RNA and other biohazards.

All work involving biohazards, including recombinant or synthetic DNA/RNA, is reviewed by the Institutional Biosafety Committee (IBC) and EH&S. The National Institutes of Health (NIH) require us to have an IBC. The committee approves procedures for procurement, use, storage, transportation and disposal of biohazardous material.